• EM Systems stands out with exceptional value metrics, including a remarkably low PEG ratio of 0.28 and significant upside potential (current price: ¥787 vs analyst target: ¥1,300). • The company demonstrates impressive profitability with an 18.4% operating margin and robust ROE of 11.7%, supported by recent quarterly profit growth of 70.4%. • Strong market momentum is evident with 14.3% price appreciation over six months, complemented by an attractive 4.9% dividend yield and 11.4% dividend growth. • As the dominant player (43.7% market share) in pharmacy IT systems in Japan, EM Systems is strategically positioned to benefit from healthcare digital transformation initiatives while expanding into clinics and long-term care segments. • The company’s strong financial position, with low debt and consistent execution, provides a solid foundation for continued growth through both organic expansion and strategic acquisitions.